Cross Country Healthcare: Boston Partners reports 0%

Cross Country Healthcare completed its merger with an affiliate of Knox Lane on July 21, 2026.

Available on EDGAR 11/06/2026 - 06:39 PM EST Accepted by SEC EDGAR 11/06/2026 - 06:38 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Cross Country Healthcare completed its merger with an affiliate of Knox Lane on July 21, 2026. Each outstanding common share was converted into the right to receive $13.25 in cash, and the common stock was delisted. Boston Partners reported beneficial ownership of 0 shares, or 0%, as of September 30, 2026.

1 point · 1 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 0 points

How the balance works

Positive

• Major pointThe merger closed with $13.25 in cash per outstanding share.

Negative

• None.

Key Figures

Merger consideration: $13.25 in cash per share Beneficially owned: 0 shares Percent of class: 0%

3 metrics

Merger consideration $13.25 in cash per share Each outstanding common share was converted into the right to receive this amount in the merger completed July 21, 2026

Beneficially owned 0 shares Boston Partners, as of September 30, 2026

Percent of class 0% Boston Partners, as of September 30, 2026

Key Terms

beneficially owned, Sole Voting Power, Shared Dispositive Power

3 terms

beneficially owned regulatory

"Boston Partners beneficially owned no shares of the Issuer"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power regulatory

"Sole Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Shared Dispositive Power regulatory

"Shared Dispositive Power 0.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What happened to CCRN shares in the merger?

Each outstanding Cross Country Healthcare common share was converted into the right to receive $13.25 in cash when the merger with an affiliate of Knox Lane was completed on July 21, 2026. The common stock was delisted.

How many CCRN shares did Boston Partners own after the merger?

Boston Partners reported beneficial ownership of 0 shares, or 0%, as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

CROSS COUNTRY HEALTHCARE INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

227483104

(CUSIP Number)

09/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 227483104

1

Names of Reporting Persons

Boston Partners

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: On July 21, 2026, the Issuer completed its merger with an affiliate of Knox Lane, pursuant to which each outstanding share of Common Stock was converted into the right to receive $13.25 in cash, and the Common Stock was delisted. As of 09/30/2026, Boston Partners beneficially owned no shares of the Issuer.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: CROSS COUNTRY HEALTHCARE INC
(b)	Address of issuer's principal executive offices: 5201 CONGRESS AVENUE, SUITE 160, BOCA RATON, FLORIDA 33487
Item 2.
(a)	Name of person filing: Boston Partners
(b)	Address or principal business office or, if none, residence: ONE BEACON STREET 30TH FLOOR BOSTON, Massachusetts 02108
(c)	Citizenship: Boston Partners - DELAWARE
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 227483104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Boston Partners - 0
	(ii) Shared power to vote or to direct the vote: Boston Partners - 0
	(iii) Sole power to dispose or to direct the disposition of: Boston Partners - 0
	(iv) Shared power to dispose or to direct the disposition of: Boston Partners - 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Boston Partners

Signature:	/s/ Ali Farooqi
Name/Title:	Ali Farooqi / Senior Compliance Manager
Date:	11/06/2026